GM1 Gangliosidosis, Type I

·MeSH: Rare Diseases

Prevalence

0.5 / 100K

0 drugs in development·0 companies·1 clinical trial

Frequently asked questions

How many clinical trials target GM1 Gangliosidosis, Type I?

There are 1 clinical trial targeting GM1 Gangliosidosis, Type I tracked by BioSniper.

What is the prevalence of GM1 Gangliosidosis, Type I?

The estimated prevalence of GM1 Gangliosidosis, Type I is approximately 0.5 per 100,000 population.

Deep-dive into GM1 Gangliosidosis, Type I

Full trial data, competitive analysis, and AI-powered pipeline tracking.

Start Free Analysis
    GM1 Gangliosidosis, Type I — Drugs in Development & Clinical Trials | BioSniper